national health regulatory agency approves trial of oxford covid-19 vaccine
national health regulatory agency approves trial of oxford covid-19 vaccine
we are delighted to be working with the talented team of investigators in brazil on the covid19 vaccine trial, as researchers and scientists around the world collaborate on clinical development work with unprecedented urgency to combat the global threat to human health that is coronavirus. says professor andrew pollard, chief investigator of the oxford vaccine trial at oxford university.", "brazil is a priority for the study because of the ascendant curve of the covid-19.", "on 2 june, the brazilian health regulatory agency (anvisa) approved the inclusion of brazil in the clinical trials conducted by oxford university and supported by astrazeneca, considering 2,000 volunteers to be tested in the country."


































)